Deadly protest in Jerusalem as ultra-Orthodox Jews rally against military draft plans
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Judge likely to order USDA to use contingency funds to keep some SNAP payments flowing during government shutdown.
Deadly protest in Jerusalem as ultra-Orthodox Jews rally against military draft plans
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Judge likely to order USDA to use contingency funds to keep some SNAP payments flowing during government shutdown.